RYBELSUS (Novo Nordisk)
(https://rybelsus.com) 📸 Data Snapshot: June 19, 2026
Information Density — The Lens
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Info Density
Power-words vs. Substance ratio.
26
Impact Weight: 30 / 100
87% Reputation
The information density is exceptionally high for a commercial site, with a low ratio of power-word fluff to substantive data. Headings like RYBELSUS lowered blood sugar better than a leading branded pill are immediately followed by specific metrics such as -1.3% on 14 mg of RYBELSUS compared to -0.8% on 100 mg of JANUVIA. Body text avoids vague adjectives in favor of technical protocols, citing a 6-month medical study in 1864 adults. The site prioritizes clinical results over revolutionary marketing slogans, creating a high substance-to-signal ratio.
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://rybelsus.com) Type 2 Diabetes Medicine | RYBELSUS® (semaglutide) tablets
[IMG: Troy standing with his dog and camera] Once-daily RYBELSUS® (semaglutide) tablets is a prescription medicine used along with diet and exercise to improve blood sugar in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for these events. LEARN ABOUT RYBELSUS® [IMG: A1C Down arrow] [IMG: A1C Down arrow] [H2] RYBELSUS® lowered blood sugar better than a leading branded pilla Adults with an average starting A1C of 8.3% lowered their A1C by an average of: -1.0% on 7 mg of RYBELSUS®-1.3% on 14 mg of RYBELSUS®-0.8% on 100 mg of JANUVIA® SEE STUDY RESULTS aResults are from a 6-month medical study in 1864 adults with type 2 diabetes that compared RYBELSUS® 7 mg and 14 mg with JANUVIA® 100 mg when both were added to 1 or 2 diabetes pills. Individual results may vary. [IMG: Down arrow] Get your A1C DOWN with RYBELSUS® Once-daily RYBELSUS® is proven to significantly lower A1C. LEARN MORE EXPAND COLLAPSE [IMG: Rx logo] [H2] There are newly available doses of semaglutide tablets Before your current prescription refills run out, contact your health care professional for an updated prescription Learn more here
1603 chars
SUB-PAGE (https://rybelsus.com/why-rybelsus/rybelsus-results.html) RYBELSUS® Results | RYBELSUS® (semaglutide) tablets 7 mg or 14 mg
[H1] RYBELSUS® Results [H2] RYBELSUS®—All of This in 1 Pill [H2] RYBELSUS®—All of This in 1 Pill [IMG: A1C down arrow] [IMG: A1C down arrow] Lowers blood sugar and A1C SEE MORE [IMG: Scale] [IMG: Scale] May help you lose some weight SEE MORE [IMG: Heart rate monitor] [IMG: Heart rate monitor] Does not increase the risk of major cardiovascular (CV) events, such as heart attack, stroke, or death SEE MORE [IMG: A1C down arrow] [IMG: A1C down arrow] Lowers blood sugar and A1C SEE MORE [IMG: Scale] [IMG: Scale] May help you lose some weight SEE MORE [IMG: Heart rate monitor] [IMG: Heart rate monitor] Does not increase the risk of major cardiovascular (CV) events such as heart attack, stroke, or death SEE MORE [IMG: A1C down arrow] [H2] Get your A1C down Once-daily RYBELSUS® is proven to significantly lower A1C, along with diet and exercise. In a 6-month study, the majority of people taking RYBELSUS® reached an A1C of less than 7% [IMG: Average change in A1C while taking 7 mg of RYBELSUS®] [IMG: Average change in A1C while taking 14 mg of RYBELSUS®] Results are from a 6-month medical study with 703 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with a sugar pill when both were added to diet and exercise. People who took a sugar pill had a 0.3% lowering of A1C, and 31% reached an A1C goal of <7%. [H4] Reaching your A1C goal is possible The American Diabetes Association (ADA) recommends an A1C goal of less than 7% for many adults with type 2 diabetes. Your healthcare provider will tell you what goal is right for you. If you're taking diabetes pills and still not at your A1C goal, talk to your healthcare provider to see if RYBELSUS® is right for you. [IMG: Scale] [H3] RYBELSUS® may help you lose some weight RYBELSUS® is a medicine for adults with type 2 diabetes that is used along with diet and exercise to improve blood sugar and A1C. While not for weight loss, it may help you lose some weight. In the same 6-month study, people lost around 8 pounds These people weighed an average of 194 pounds and took 14 mg of RYBELSUS® People who weighed an average of 196 pounds and took 7 mg of RYBELSUS® lost around 5 pounds Results are from a 6-month medical study with 703 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with a sugar pill when both were added to diet and exercise. People who weighed an average of 195 pounds and took a sugar pill lost around 3 pounds. While many people in medical studies lost weight, some did gain weight. [IMG: Heart rate monitor] [H3] RYBELSUS® and cardiovascular safety RYBELSUS® does not increase the risk of major cardiovascular (CV) events such as heart attack, stroke, or death. In a cardiovascular safety study, 3183 adults with type 2 diabetes and a high risk of CV events were treated once daily with either 14 mg RYBELSUS® or a sugar pill in addition to their usual diabetes and CV medications. NEXT: RYBELSUS® vs Other Diabetes Pills [IMG: Down arrow] Get your A1C DOWN with RYBELSUS® Once-daily RYBELSUS® is proven to significantly lower A1C. LEARN MORE [IMG: Down arrow] Get your A1C DOWN with RYBELSUS® Once-daily RYBELSUS® is proven to significantly lower A1C. LEARN MORE EXPAND COLLAPSE
4466 chars
SUB-PAGE (https://rybelsus.com/why-rybelsus/rybelsus-vs-other-diabetes-pills.html) RYBELSUS® vs Other Diabetes Pills | RYBELSUS® (semaglutide) tablets 7 mg or 14 mg
[H1] RYBELSUS® vs Other Diabetes Pills Once-daily RYBELSUS® is a prescription medicine used along with diet and exercise to improve blood sugar in adults with type 2 diabetes. [H2] RYBELSUS® vs a leading branded pill (JANUVIA®) [IMG: A1C down arrow] [H3] RYBELSUS® lowered blood sugar better At 6 months, adults with an average starting A1C of 8.3% lowered their A1C by an average of: [IMG: Average change in A1C comparison] Results are from a 6-month medical study of 1864 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with 100 mg JANUVIA® when both were added to 1 or 2 diabetes pills. [IMG: Scale] [H3] While RYBELSUS® is not for weight loss, you may also lose some weight At 6 months, in the same study looking at A1C, people who weighed an average of 200 pounds, on average, lost around: 4.8 pounds while taking 7 mg of RYBELSUS®6.8 pounds while taking 14 mg of RYBELSUS®1.3 pounds while taking 100 mg of JANUVIA® [IMG: Light bulb] People taking 14 mg of RYBELSUS® lost 5x more weight than people taking JANUVIA®. Results are from a 6-month medical study of 1864 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with 100 mg JANUVIA® when both were added to 1 or 2 diabetes pills. While many people in medical studies lost weight, some did gain weight. [H2] Need to get your A1C DOWN? RYBELSUS® is a prescription medicine for type 2 diabetes that is used along with diet and exercise to improve blood sugar and A1C. Learn ways to make diet and exercise a part of your daily routine. LEARN MORE [H2] Need to get your A1C DOWN? RYBELSUS® is a prescription medicine for type 2 diabetes that is used along with diet and exercise to improve blood sugar and A1C. Learn ways to make diet and exercise a part of your daily routine. LEARN MORE [H2] Need to get your A1C DOWN? RYBELSUS® is a prescription medicine for type 2 diabetes that is used along with diet and exercise to improve blood sugar and A1C. Learn ways to make diet and exercise a part of your daily routine. LEARN MORE [H2] RYBELSUS® vs JARDIANCE® [IMG: A1C down arrow] [H3] RYBELSUS® lowered blood sugar better At 6 months, adults with an average starting A1C of 8.1% lowered their A1C by an average of: [IMG: Average change in A1C comparison] Results are from a 6-month medical study of 822 adults with type 2 diabetes that compared 14 mg RYBELSUS® with 25 mg JARDIANCE® when both were added to another diabetes pill. [IMG: Scale] [H3] While RYBELSUS® is not for weight loss, you may also lose some weight At 6 months, in a medical study, people who weighed an average of 202 pounds, on average, lost around: 8.4 pounds while taking 14 mg of RYBELSUS®8.1 pounds while taking 25 mg of JARDIANCE® [IMG: Light bulb] The average weight loss was about the same in people taking 14 mg of RYBELSUS® and in people taking 25 mg of JARDIANCE®. [IMG: Light bulb] The average weight loss was about the same in people taking 14 mg of RYBELSUS® and in people taking 25 mg of JARDIANCE®. Results are from a 6-month medical study of 822 adults with type 2 diabetes that compared 14 mg RYBELSUS® with 25 mg JARDIANCE® when both were added to another diabetes pill. While many people in medical studies lost weight, some did gain weight. NEXT: How RYBELSUS® Works [IMG: Down arrow] Get your A1C DOWN with RYBELSUS® Once-daily RYBELSUS® is proven to significantly lower A1C. LEARN MORE EXPAND COLLAPSE
4436 chars
SUB-PAGE (https://rybelsus.com/why-rybelsus.html) RYBELSUS® Results | RYBELSUS® (semaglutide) tablets 7 mg or 14 mg
[H1] RYBELSUS® Results [H2] RYBELSUS®—All of This in 1 Pill [H2] RYBELSUS®—All of This in 1 Pill [IMG: A1C down arrow] [IMG: A1C down arrow] Lowers blood sugar and A1C SEE MORE [IMG: Scale] [IMG: Scale] May help you lose some weight SEE MORE [IMG: Heart rate monitor] [IMG: Heart rate monitor] Does not increase the risk of major cardiovascular (CV) events, such as heart attack, stroke, or death SEE MORE [IMG: A1C down arrow] [IMG: A1C down arrow] Lowers blood sugar and A1C SEE MORE [IMG: Scale] [IMG: Scale] May help you lose some weight SEE MORE [IMG: Heart rate monitor] [IMG: Heart rate monitor] Does not increase the risk of major cardiovascular (CV) events such as heart attack, stroke, or death SEE MORE [IMG: A1C down arrow] [H2] Get your A1C down Once-daily RYBELSUS® is proven to significantly lower A1C, along with diet and exercise. In a 6-month study, the majority of people taking RYBELSUS® reached an A1C of less than 7% [IMG: Average change in A1C while taking 7 mg of RYBELSUS®] [IMG: Average change in A1C while taking 14 mg of RYBELSUS®] Results are from a 6-month medical study with 703 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with a sugar pill when both were added to diet and exercise. People who took a sugar pill had a 0.3% lowering of A1C, and 31% reached an A1C goal of <7%. [H4] Reaching your A1C goal is possible The American Diabetes Association (ADA) recommends an A1C goal of less than 7% for many adults with type 2 diabetes. Your healthcare provider will tell you what goal is right for you. If you're taking diabetes pills and still not at your A1C goal, talk to your healthcare provider to see if RYBELSUS® is right for you. [IMG: Scale] [H3] RYBELSUS® may help you lose some weight RYBELSUS® is a medicine for adults with type 2 diabetes that is used along with diet and exercise to improve blood sugar and A1C. While not for weight loss, it may help you lose some weight. In the same 6-month study, people lost around 8 pounds These people weighed an average of 194 pounds and took 14 mg of RYBELSUS® People who weighed an average of 196 pounds and took 7 mg of RYBELSUS® lost around 5 pounds Results are from a 6-month medical study with 703 adults with type 2 diabetes that compared 7 mg RYBELSUS® and 14 mg RYBELSUS® with a sugar pill when both were added to diet and exercise. People who weighed an average of 195 pounds and took a sugar pill lost around 3 pounds. While many people in medical studies lost weight, some did gain weight. [IMG: Heart rate monitor] [H3] RYBELSUS® and cardiovascular safety RYBELSUS® does not increase the risk of major cardiovascular (CV) events such as heart attack, stroke, or death. In a cardiovascular safety study, 3183 adults with type 2 diabetes and a high risk of CV events were treated once daily with either 14 mg RYBELSUS® or a sugar pill in addition to their usual diabetes and CV medications. NEXT: RYBELSUS® vs Other Diabetes Pills [IMG: Down arrow] Get your A1C DOWN with RYBELSUS® Once-daily RYBELSUS® is proven to significantly lower A1C. LEARN MORE [IMG: Down arrow] Get your A1C DOWN with RYBELSUS® Once-daily RYBELSUS® is proven to significantly lower A1C. LEARN MORE EXPAND COLLAPSE
4466 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…
Explore the other reputation pillars for RYBELSUS (Novo Nordisk)
Analysis Disclosure & Source Attribution
This page presents a snapshot of public data from RYBELSUS (Novo Nordisk), captured on June 19, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to RYBELSUS (Novo Nordisk): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://rybelsus.com to view the most current version of its content and see directly what this company is about and what it offers.